424 related articles for article (PubMed ID: 28472255)
1. Clinical Outcomes of Patients With Drug-Resistant Tuberculous Meningitis Treated With an Intensified Antituberculosis Regimen.
Heemskerk AD; Nguyen MTH; Dang HTM; Vinh Nguyen CV; Nguyen LH; Do TDA; Nguyen TTT; Wolbers M; Day J; Le TTP; Nguyen BD; Caws M; Thwaites GE
Clin Infect Dis; 2017 Jul; 65(1):20-28. PubMed ID: 28472255
[TBL] [Abstract][Full Text] [Related]
2. Antituberculosis drug resistance patterns in adults with tuberculous meningitis: results of haydarpasa-iv study.
Senbayrak S; Ozkutuk N; Erdem H; Johansen IS; Civljak R; Inal AS; Kayabas U; Kursun E; Elaldi N; Savic B; Simeon S; Yilmaz E; Dulovic O; Ozturk-Engin D; Ceran N; Lakatos B; Sipahi OR; Sunbul M; Yemisen M; Alabay S; Beovic B; Ulu-Kilic A; Cag Y; Catroux M; Inan A; Dragovac G; Deveci O; Tekin R; Gul HC; Sengoz G; Andre K; Harxhi A; Hansmann Y; Oncu S; Kose S; Oncul O; Parlak E; Sener A; Yilmaz G; Savasci U; Vahaboglu H
Ann Clin Microbiol Antimicrob; 2015 Nov; 14():47. PubMed ID: 26538030
[TBL] [Abstract][Full Text] [Related]
3. Influence of antituberculosis drug resistance and Mycobacterium tuberculosis lineage on outcome in HIV-associated tuberculous meningitis.
Tho DQ; Török ME; Yen NT; Bang ND; Lan NT; Kiet VS; van Vinh Chau N; Dung NH; Day J; Farrar J; Wolbers M; Caws M
Antimicrob Agents Chemother; 2012 Jun; 56(6):3074-9. PubMed ID: 22470117
[TBL] [Abstract][Full Text] [Related]
4. Intensified treatment with high dose rifampicin and levofloxacin compared to standard treatment for adult patients with tuberculous meningitis (TBM-IT): protocol for a randomized controlled trial.
Heemskerk D; Day J; Chau TT; Dung NH; Yen NT; Bang ND; Merson L; Olliaro P; Pouplin T; Caws M; Wolbers M; Farrar J
Trials; 2011 Feb; 12():25. PubMed ID: 21288325
[TBL] [Abstract][Full Text] [Related]
5. Intensified Antituberculosis Therapy in Adults with Tuberculous Meningitis.
Heemskerk AD; Bang ND; Mai NT; Chau TT; Phu NH; Loc PP; Chau NV; Hien TT; Dung NH; Lan NT; Lan NH; Lan NN; Phong le T; Vien NN; Hien NQ; Yen NT; Ha DT; Day JN; Caws M; Merson L; Thinh TT; Wolbers M; Thwaites GE; Farrar JJ
N Engl J Med; 2016 Jan; 374(2):124-34. PubMed ID: 26760084
[TBL] [Abstract][Full Text] [Related]
6. Impact of drug resistance on clinical outcome in children with tuberculous meningitis.
Seddon JA; Visser DH; Bartens M; Jordaan AM; Victor TC; van Furth AM; Schoeman JF; Schaaf HS
Pediatr Infect Dis J; 2012 Jul; 31(7):711-6. PubMed ID: 22411053
[TBL] [Abstract][Full Text] [Related]
7. Long-term Mortality of Patients With Tuberculous Meningitis in New York City: A Cohort Study.
Vinnard C; King L; Munsiff S; Crossa A; Iwata K; Pasipanodya J; Proops D; Ahuja S
Clin Infect Dis; 2017 Feb; 64(4):401-407. PubMed ID: 27927856
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of levofloxacin versus rifampicin in tuberculous meningitis: an open-label randomized controlled trial.
Kalita J; Misra UK; Prasad S; Bhoi SK
J Antimicrob Chemother; 2014 Aug; 69(8):2246-51. PubMed ID: 24752957
[TBL] [Abstract][Full Text] [Related]
9. Isoniazid and rifampicin heteroresistant Mycobacterium tuberculosis isolated from tuberculous meningitis patients in India.
Gupta R; Thakur R; Kushwaha S; Jalan N; Rawat P; Gupta P; Aggarwal A; Gupta M; Manchanda V
Indian J Tuberc; 2018 Jan; 65(1):52-56. PubMed ID: 29332649
[TBL] [Abstract][Full Text] [Related]
10. The chemotherapy of tuberculous meningitis in children and adults.
Donald PR
Tuberculosis (Edinb); 2010 Nov; 90(6):375-92. PubMed ID: 20810322
[TBL] [Abstract][Full Text] [Related]
11. Effect of antituberculosis drug resistance on response to treatment and outcome in adults with tuberculous meningitis.
Thwaites GE; Lan NT; Dung NH; Quy HT; Oanh DT; Thoa NT; Hien NQ; Thuc NT; Hai NN; Bang ND; Lan NN; Duc NH; Tuan VN; Hiep CH; Chau TT; Mai PP; Dung NT; Stepniewska K; White NJ; Hien TT; Farrar JJ
J Infect Dis; 2005 Jul; 192(1):79-88. PubMed ID: 15942897
[TBL] [Abstract][Full Text] [Related]
12. Decreased mortality seen in rifampicin/multidrug-resistant tuberculous meningitis treated with linezolid in Shenzhen, China.
Fang MT; Su YF; An HR; Zhang PZ; Deng GF; Liu HM; Mao Z; Zeng JF; Li G; Yang QT; Wang ZY
BMC Infect Dis; 2021 Sep; 21(1):1015. PubMed ID: 34583653
[TBL] [Abstract][Full Text] [Related]
13. Analytical and clinical performance characteristics of the Abbott RealTime MTB RIF/INH Resistance, an assay for the detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis in pulmonary specimens.
Kostera J; Leckie G; Tang N; Lampinen J; Szostak M; Abravaya K; Wang H
Tuberculosis (Edinb); 2016 Dec; 101():137-143. PubMed ID: 27865383
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of additional levofloxacin in tuberculous meningitis: A randomized controlled pilot study.
Kalita J; Bhoi SK; Betai S; Misra UK
Tuberculosis (Edinb); 2016 May; 98():1-6. PubMed ID: 27156611
[TBL] [Abstract][Full Text] [Related]
15. Naïve-pooled pharmacokinetic analysis of pyrazinamide, isoniazid and rifampicin in plasma and cerebrospinal fluid of Vietnamese children with tuberculous meningitis.
Pouplin T; Bang ND; Toi PV; Phuong PN; Dung NH; Duong TN; Caws M; Thwaites GE; Tarning J; Day JN
BMC Infect Dis; 2016 Apr; 16():144. PubMed ID: 27039088
[TBL] [Abstract][Full Text] [Related]
16. Familial outbreak of disseminated multidrug-resistant tuberculosis and meningitis.
Sofia M; Maniscalco M; Honoré N; Molino A; Mormile M; Heym B; Cole ST
Int J Tuberc Lung Dis; 2001 Jun; 5(6):551-8. PubMed ID: 11409583
[TBL] [Abstract][Full Text] [Related]
17. Comparative evaluation of intensified short course regimen and standard regimen for adults TB meningitis: a protocol for an open label, multi-center, parallel arms, randomized controlled superiority trial (INSHORT trial).
Inbaraj LR; Manesh A; Ponnuraja C; Bhaskar A; Srinivasalu VA; Daniel BD
Trials; 2024 May; 25(1):294. PubMed ID: 38693583
[TBL] [Abstract][Full Text] [Related]
18. Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial.
Ruslami R; Ganiem AR; Dian S; Apriani L; Achmad TH; van der Ven AJ; Borm G; Aarnoutse RE; van Crevel R
Lancet Infect Dis; 2013 Jan; 13(1):27-35. PubMed ID: 23103177
[TBL] [Abstract][Full Text] [Related]
19. Emergence and selection of isoniazid and rifampin resistance in tuberculosis granulomas.
Pienaar E; Linderman JJ; Kirschner DE
PLoS One; 2018; 13(5):e0196322. PubMed ID: 29746491
[TBL] [Abstract][Full Text] [Related]
20. Combinatory activity of linezolid and levofloxacin with antituberculosis drugs in Mycobacterium tuberculosis.
Santos NCS; Scodro RBL; de Almeida AL; Baldin VP; Nakamura de Vasconcelos SS; Siqueira VLD; Caleffi-Ferracioli KR; Campanerut-Sá PAZ; Cardoso RF
Tuberculosis (Edinb); 2018 Jul; 111():41-44. PubMed ID: 30029913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
